Science and Research

Cannabimovone was shown to increase sensitivity to insulin

A university-run clinical trial showed a significant reduction of insomnia with minimal side effects

Intoxicated people should be considered vulnerable witnesses by police, lawyer says

GemmaCert could prevent mistaken drug busts and benefit medical cannabis patients

The free web service recommends your ideal strains based on a database of product descriptions and over 600 medical articles

The cannabis-based medicine could treat seizures associated with Tuberous Sclerosis Complex

Wind pollinating plants, like cannabis and hemp, don't provide enough nutrition to sustain bees

Dr. Ian Mitchell of Kamloops is calling out medical professionals across Canada for spreading misinformation on pot

Researchers found the cannabinoids exhibit anti-tumour properties

InMed Pharmaceuticals has initiated a clinical trial for its epidermolysis bullosa treatment, after regulatory approval in December

It may have been a sobering year for the legal weed industry, but cannabis still made major waves in society, politics and science in 2019

While the impairment may be different, the effect is the same: decreased reaction time and increased danger, according to a chief safety strategist

Almost 19 per cent of survey respondents with depression reported using pot over the last 30 days

RYAH Medtech is gearing up to enter more foreign markets and list on the CSE

Tetra Bio-Pharma’s stock continues to rise after announcing more trials at no additional cost to shareholders

Altas Biotechnologies Inc. donated nearly $300,000 to U of A for research over the next 2 years

Can cannabis ... is a new series where Mugglehead journalists investigate controversial claims about the uses of weed, in an effort to inform our readers and move the conversation forward.

Tissue culture uses less space and labour than the traditional trimming cloning method

The study showed inhaling cannabis reduced migraine severity by 49.6 per cent

But the authors of the research published in JAMA Psychiatry say it doesn't mean legalization is a bad idea

Questions remain as to whether impairment should be measured by blood-THC or cognitive functioning

First-of-its-kind research points to cannabis as a treatment for PTSD symptoms

Tilray shares jumped after announcing it successfully imported medical cannabis into the U.S. in support of a new clinical trial on its use for treating breast cancer drug side effects

Ikänik Farms is looking to go public in the next several months, and CEO Brian Baca tells Mugglehead its Pideka acquisition will "crush everybody coming out of Canada" with its low-cost cultivation and export potential.

Mugglehead talks to Everett Knight, executive vice president of strategy and investments at Valens, how the extraction company's focus on quality is helping it land big contracts ahead of Cannabis 2.0.

The two companies said they have been pouring in resources the last five months to develop water soluble pot drinks they expect will make a big splash in the $2.7 billion derivatives market.

Researchers at the Mayo Clinic examine lung tissue samples from 17 patients associated with the vaping health crisis that has sickened 1,080 Americans since April.

With more than 800 cases of vape-related lung disorders and 17 confirmed deaths, 800 cannabis companies signed a letter to Congress to regulate the industry to keep consumers safe.

The study, published in the Journal of Neuroscience, shows for the first time how CBD cancels out the negative side-effects of THC in rats such as paranoia, anxiety and addictive behaviours.

U.S. Epidiolex sales have surged on strong patient uptake and now the CBD-based epilepsy drug could be sold in 31 European countries after EU authorities gave GW the green light.

Amid a breakout of vape-related lung illnesses in the U.S., the industry is calling for products to be regulated, while in Canada, pot firms say their legal vapes are rigorously tested and safe.

Mugglehead speaks with Dr. Arup Sen, chief science officer at Sproutly, about its industry-leading technology used to develop high quality infused beverages with precise THC dosing.

Mugglehead talks to University of British Columbia's M-J Milloy who is studying how cannabis might help with opioid addiction while big pharma is being sued for millions.

The recent University of Michigan survey comes on the heals of a separate U.S. report that shows high school students are using less pot, but either way, the industry knows it needs to show social responsibility.

Two deaths and hundreds of cases of a mysterious lung illness all linked to vaping e-cigarettes or illegal cannabis oil in the U.S. has sparked investigations in Canada and south of the border.

The U.S. Centers for Disease Control is investigating 94 reports of people in hospitals with vape-related lung illnesses across 14 states with a number of cases related to the use of illegal cannabis vape cartridges.

A Tel Aviv-based team at Weedley is launching several clinical studies to test if CBD is an effective and safe way to treat pain in dogs and horses.

Aurora and the UFC plan to conduct clinical trials to study how CBD can help the elite athletes and the results will be used develop a new line of hemp-derived topical products.

Health Canada has only approved only 65 of approximately 600 cannabis research applications since legalization took place Oct. 17, according to a recent CTV News report.

It took eight years and $83 million dollars for Tel Aviv-based Syqe Medical to develop the new product that will allow medical marijuana patients to take accurate doses.